Latest ORBIMED ADVISORS LLC Stock Portfolio
ORBIMED ADVISORS LLC Performance:
2024 Q3: 5.8%YTD: 19.13%2023: 1.22%
Performance for 2024 Q3 is 5.8%, and YTD is 19.13%, and 2023 is 1.22%.
About ORBIMED ADVISORS LLC and 13F Hedge Fund Stock Holdings
ORBIMED ADVISORS LLC is a hedge fund based in NEW YORK, NY. On 29-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $18.3 Billions. In it's latest 13F Holdings report, ORBIMED ADVISORS LLC reported an equity portfolio of $5.5 Billions as of 30 Sep, 2024.
The top stock holdings of ORBIMED ADVISORS LLC are EWTX, SVA, LLY. The fund has invested 7.3% of it's portfolio in EDGEWISE THERAPEUTICS INC and 6.2% of portfolio in SINOVAC BIOTECH LTD.
The fund managers got completely rid off VERONA PHARMA PLC (VRNA), DEXCOM INC (DXCM) and HERON THERAPEUTICS INC (HRTX) stocks. They significantly reduced their stock positions in JANUX THERAPEUTICS INC (JANX), VAXCYTE INC (PCVX) and RHYTHM PHARMACEUTICALS INC (RYTM). ORBIMED ADVISORS LLC opened new stock positions in MBX BIOSCIENCES INC, UNIVERSAL HLTH SVCS INC (UHS) and PHATHOM PHARMACEUTICALS INC (PHAT). The fund showed a lot of confidence in some stocks as they added substantially to STRUCTURE THERAPEUTICS INC, C4 THERAPEUTICS INC (CCCC) and REGENERON PHARMACEUTICALS (REGN).
The top stock holdings of ORBIMED ADVISORS LLC are EWTX, SVA, LLY. The fund has invested 7.3% of it's portfolio in EDGEWISE THERAPEUTICS INC and 6.2% of portfolio in SINOVAC BIOTECH LTD.
The fund managers got completely rid off VERONA PHARMA PLC (VRNA), DEXCOM INC (DXCM) and HERON THERAPEUTICS INC (HRTX) stocks. They significantly reduced their stock positions in JANUX THERAPEUTICS INC (JANX), VAXCYTE INC (PCVX) and RHYTHM PHARMACEUTICALS INC (RYTM). ORBIMED ADVISORS LLC opened new stock positions in MBX BIOSCIENCES INC, UNIVERSAL HLTH SVCS INC (UHS) and PHATHOM PHARMACEUTICALS INC (PHAT). The fund showed a lot of confidence in some stocks as they added substantially to STRUCTURE THERAPEUTICS INC, C4 THERAPEUTICS INC (CCCC) and REGENERON PHARMACEUTICALS (REGN).
ORBIMED ADVISORS LLC Annual Return Estimates Vs S&P 500
Our best estimate is that ORBIMED ADVISORS LLC made a return of 5.8% in the last quarter. In trailing 12 months, it's portfolio return was 31.29%.
New Buys
| Ticker | $ Bought |
|---|---|
| mbx biosciences inc | 99,041,300 |
| universal hlth svcs inc | 35,725,600 |
| bioage labs inc | 29,608,200 |
| phathom pharmaceuticals inc | 26,199,200 |
| cg oncology inc | 26,075,700 |
| corbus pharmaceuticals hldgs | 18,825,900 |
| medpace hldgs inc | 14,987,600 |
| gilead sciences inc | 12,718,500 |
New stocks bought by ORBIMED ADVISORS LLC
Additions
| Ticker | % Inc. |
|---|---|
| structure therapeutics inc | 206 |
| c4 therapeutics inc | 189 |
| regeneron pharmaceuticals | 98.25 |
| lexicon pharmaceuticals inc | 88.57 |
| verastem inc | 87.2 |
| amgen inc | 87.03 |
| nkarta inc | 85.08 |
| integer hldgs corp | 64.65 |
Additions to existing portfolio by ORBIMED ADVISORS LLC
Reductions
| Ticker | % Reduced |
|---|---|
| janux therapeutics inc | -57.76 |
| vaxcyte inc | -51.38 |
| rhythm pharmaceuticals inc | -38.16 |
| elevance health inc | -36.82 |
| evolent health inc | -36.1 |
| thermo fisher scientific inc | -36.06 |
| tenet healthcare corp | -33.35 |
| neurocrine biosciences inc | -32.57 |
ORBIMED ADVISORS LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| biomx inc | -4,629,320 |
| apollomics inc | -1,806,460 |
| heron therapeutics inc | -22,795,000 |
| verona pharma plc | -41,381,600 |
| alx oncology hldgs inc | -11,423,600 |
| lakeshore biopharma co ltd | -909,833 |
| traws pharma inc | -466,918 |
| morphic hldg inc | -20,867,900 |
ORBIMED ADVISORS LLC got rid off the above stocks
Sector Distribution
ORBIMED ADVISORS LLC has about 74.3% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 74.3 |
| Others | 23.4 |
| 2.2 |
Market Cap. Distribution
ORBIMED ADVISORS LLC has about 39.9% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 28.8 |
| UNALLOCATED | 23.7 |
| SMALL-CAP | 18.8 |
| MID-CAP | 12.5 |
| MEGA-CAP | 11.1 |
| MICRO-CAP | 4.8 |
Stocks belong to which Index?
About 57.9% of the stocks held by ORBIMED ADVISORS LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 42.1 |
| S&P 500 | 30.7 |
| RUSSELL 2000 | 27.2 |
ORBIMED ADVISORS LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of ORBIMED ADVISORS LLC
ORBIMED ADVISORS LLC has 109 stocks in it's portfolio. About 41.6% of the portfolio is in top 10 stocks. BIIB proved to be the most loss making stock for the portfolio. EWTX was the most profitable stock for ORBIMED ADVISORS LLC last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABCL | abcellera biologics inc | 0.20 | 4,180,770 | 10,870,000 | unchanged | 0.00 | ||
| ACAD | acadia pharmaceuticals inc | 0.21 | 764,600 | 11,759,500 | new | |||
| ACET | adicet bio inc | 0.30 | 11,447,100 | 16,483,900 | unchanged | 0.00 | ||
| ADCT | adc therapeutics sa | 0.26 | 4,533,800 | 14,281,500 | added | 5.03 | ||
| ADGI | invivyd inc | 0.03 | 1,728,300 | 1,762,870 | reduced | -28.75 | ||
| ALNY | alnylam pharmaceuticals inc | 1.25 | 250,300 | 68,840,000 | unchanged | 0.00 | ||
| ALXO | alx oncology hldgs inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AMGN | amgen inc | 1.48 | 252,300 | 81,293,600 | added | 87.03 | ||
| APLS | apellis pharmaceuticals inc | 0.67 | 1,270,400 | 36,638,300 | reduced | -2.49 | ||
| AVTX | avalo therapeutics inc | 0.17 | 967,000 | 9,186,500 | new | |||
| BIIB | biogen inc | 2.86 | 813,000 | 157,592,000 | reduced | -9.76 | ||
| BMRN | biomarin pharmaceutical inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BSX | boston scientific corp | 4.98 | 3,273,000 | 274,277,000 | unchanged | 0.00 | ||
| CCCC | c4 therapeutics inc | 0.45 | 4,377,900 | 24,954,000 | added | 189 | ||
| CGEM | cullinan therapeutics inc | 0.32 | 1,070,060 | 17,912,700 | reduced | -6.76 | ||
| CMPX | compass therapeutics inc | 0.75 | 22,362,800 | 41,147,600 | unchanged | 0.00 | ||
| CRBP | corbus pharmaceuticals hldgs | 0.34 | 912,552 | 18,825,900 | new | |||
| CRNX | crinetics pharmaceuticals in | 0.98 | 1,050,060 | 53,657,800 | reduced | -18.02 | ||
| CRVS | corvus pharmaceuticals inc | 0.67 | 6,943,650 | 36,662,500 | unchanged | 0.00 | ||
| CYTK | cytokinetics inc | 0.74 | 766,906 | 40,492,600 | reduced | -5.66 | ||